Biotech ETFs Soar on Human Genome Bid, Gilead Drug Results
April 19, 2012 at 10:55 AM EDT
Biotech ETFs were the strongest market sector by far in early trading Thursday as portfolio holdings Human Genome Sciences (NasdaqGS: HGSI) and Gilead Sciences (NasdaqGS: GILD) soared on a takeover bid and encouraging drug results. Human Genome shares rallied more than 100% following an unsolicited...
